Enthea, a Boston, MA-based provider of insurance plans for psychedelic healthcare, raised $2M in Seed funding.
The round was led by Tabula Rasa Ventures.
The company intends to use the funds to launch its services into 40 markets across the U.S. next year as well as grow its customer base and provider network.
Led by CEO Sherry Rais, Enthea is a licensed provider of health insurance benefits to cover psychedelic-assisted psychotherapies (PAP). Through its workplace benefit plans, companies can provide their employees’ coverage for these important mental health treatment options. Enthea’s plans cover a wide range of mental health conditions affecting tens of millions of people. The company medical policies are evidence-based and guided by expert panels. To deliver this treatment, Enthea is building a nationwide network of credentialed clinics and therapists, opening in 40 US cities in 2023. The company’s plans currently cover ketamine-based treatments and they will add MDMA and psilocybin medicines as they are approved.
FinSMEs
12/12/2022